Completed PHASE4 INTERVENTIONAL 2-arm NCT00646945

Study of the Efficacy of Kalinox® 170 Bar in Adult Oncology

International, Randomized, Controled, Double-Blind Study Assessing Efficacy of Kalinox® 170 Bar During the Realization of Invasive Gestures in Adult Oncology

Sponsor: Air Liquide Santé International

Conditions Cancer Pain

Interventions 50% Oxygen/50% Nitrogen premix 50% Oxygen/50% Nitrous oxide premix (Kalinox 170 bar)

Updated 7 times since 2017 Last updated: Sep 10, 2025 Started: Sep 30, 2007 Primary completion: Oct 31, 2008 Completion: Oct 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Cancer and Pain, this trial is completed. The trial is conducted by Air Liquide Santé International and has accumulated 7 data snapshots since 2007. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Oct 2025 — Present [monthly]

Completed PHASE4
Sep 2025 — Oct 2025 [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Sep 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Air Liquide Santé International

Data source: Air Liquide Santé International

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Vandœuvre-lès-Nancy, France